$250 | Single User
$500 | Site License
$750 | Global License

Shanghai Fosun Pharmaceutical (Group) Co Ltd (600196) - Medical Equipment - Deals and Alliances Profile [Report Updated: 23-10-2018]

Published by Global Data: 23 Oct 2018 | 226033 | In Stock

Introduction

Summary

Shanghai Fosun Pharmaceutical (Group) Co Ltd (Fosun Pharma), a subsidiary of Shanghai Fosun High Technology (Group) Co Ltd is a drug company that offers pharmaceutical products, medical diagnostic products and medical device products. The company’s pharmaceutical products include metabolism and digestive system, cardiovascular system, blood system, central nervous system drugs, anti-infection, anti-tumor, vaccine and raw material and intermediates. It provides medical diagnostic products such as real time PCR detector, human papillomavirus assay kit, HBV quantitative reagent, and biofosun microorganism identification and susceptibility analysis system. The company's research and development unit concentrates on therapeutic areas of metabolism and digestive system, blood system, cardiovascular system and central nervous system. Fosun Pharma is headquartered in Shanghai City, Shanghai, China.

Shanghai Fosun Pharmaceutical (Group) Co Ltd (600196) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.

- Business Description - A brief description of the company's operations.

- Key Employees - A list of the key executives of the company.

- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors - A list of the key competitors of the company.

- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table of Contents
for Shanghai Fosun Pharmaceutical (Group) Co Ltd (600196) - Medical Equipment - Deals and Alliances Profile [Report Updated: 23-10-2018]

  • Table of Contents

    Table of Contents 3

    List of Tables 5

    List of Figures 5

    Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

    Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 7

    Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

    Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 9

    Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

    Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Deal Details 13

    Venture Financing 13

    Paragon Genomics Raises USD8 Million in Series A Financing 13

    Spirometrix Raises USD17.4 Million in Series C Financing 14

    Check-Cap Raises Funds through Venture Financing 15

    Saladax Biomedical Raises US Million In Series D Venture Financing 16

    Private Equity 18

    Butterfly Network Raises USD250 Million in Series D Financing 18

    Healthy Harmony and Shanghai Fosun Pharma Acquire Chindex International in Going Private Transaction for USD461 Million 19

    PBM Capital Acquires Breas Medical From GE Healthcare 21

    KKR Receives Government Approval To Acquire 35% Stake In Gland Pharma For USD200 Million 22

    Partnerships 23

    Shanghai Fosun Pharma Plans to Form Joint Venture with Fosun International 23

    Intuitive Surgical to Form Joint Venture with Shanghai Fosun Pharma 24

    Astute Medical Enters into Distribution Agreement with Fosun Long March 25

    CareFusion Enters into Distribution Agreement with Breas Medical for Vivo Line of Ventilators 26

    Miacom Diagnostics Enters into Co-Marketing Agreement with Fosun Diagnostics 27

    Equity Offering 28

    Shanghai Fosun Pharma Raises USD331 Million in Private Placement of Shares 28

    Gland Pharma May Raise USD500 Million in IPO 30

    Shanghai Fosun Pharma to Raise USD298.3 Million in Private Placement of Shares 31

    Chindex to Raise USD38.2 Million in Private Placement of Shares 33

    Debt Offering 34

    Shanghai Fosun Pharma Raises USD190.7 Million in Public Offering of 5.1% Bonds Due 2023 34

    Shanghai Fosun Pharma to Raise USD791 Million in Public Offering of Bonds 35

    Shanghai Fosun Pharma Plans to Raise up to USD1 Billion in Private Placement of Bonds 36

    Shanghai Fosun Pharma Raises USD65.3 Million in First Tranche of Private Placement of 3.95% Notes Due 2018 37

    Acquisition 38

    Shanghai Fosun Pharma to Acquire 65% Stake in SinoMedCare Biotech for USD40 Million 38

    Fosun Pharma Acquires 80% stake in Breas Medical 39

    Breas Medical Acquires B&D Electromedical 40

    Shanghai Fosun Pharma Acquires 37% Stake in miacom diagnostics 41

    Shanghai Fosun to Acquire 35% Stake in Sinopharm Holding Medical Investment Management from Sinopharm Group for up to USD32.4 Million 42

    Fosun Pharma And Pramerica-Fosun China Opportunity Fund Complete Acquisition Of 95.6% Stake In Alma Lasers For US0 Million 43

    Shanghai Fosun Pharma Acquires 17.65% Stake In SD Biosensor, In Vitro Diagnostics Company 45

    Shanghai Fosun Pharmaceutical (Group) Co Ltd - Key Competitors 46

    Shanghai Fosun Pharmaceutical (Group) Co Ltd - Key Employees 47

    Shanghai Fosun Pharmaceutical (Group) Co Ltd - Locations And Subsidiaries 49

    Head Office 49

    Other Locations & Subsidiaries 49

    Recent Developments 50

    Strategy And Business Planning 50

    Sep 05, 2017: Sisram, the world's leading medical and medical device company under Fosun Pharma, plans to become the first listed Israeli company in Hong Kong 50

    Jul 11, 2017: Rooted in Shanghai innovation Fosun Pharma Zhangjiang new R & D headquarters base was officially launched 52

    Financial Announcements 54

    Mar 27, 2018: Fosun pharma: Announcement of Final Results for the Year Ended 31 December 2017 54

    Oct 31, 2017: Fosun Pharma releases third quarter 2017 revenue up 21.83% YoY Research and development investment continues to increase 56

    Aug 30, 2017: Fosun Pharma: R & D and international lighting performance, the first half revenue grew 20.41% 57

    Jun 14, 2017: Fosun Pharma released first quarter 2017 revenue up 20.29% R & D investment continued to increase 59

    Mar 31, 2017: Fosun Pharma non-net profit in 2016 increased by 26.36% year-on-year Continued to increase innovation and R & D investment Strengthen the layout of medical services 60

    Corporate Communications 63

    Mar 26, 2018: Change In Fosun Pharma’s Board Of Directors To Further Align Group Strategy 63

    Mar 26, 2018: Shanghai Fosun Pharmaceutical Announces Personnel Changes 64

    Legal and Regulatory 66

    Sep 05, 2017: Fosun Pharmas Subsidiary Sisram, the World's Leading Energy-Based Medical Aesthetic Treatment Systems Provider, to be Listed as the First Israeli Company on the Main Board of SEHK 66

    Appendix 68

    Methodology 68

    About GlobalData 68

    Contact Us 68

    Disclaimer 68

List Of Tables
in Shanghai Fosun Pharmaceutical (Group) Co Ltd (600196) - Medical Equipment - Deals and Alliances Profile [Report Updated: 23-10-2018]

List of Tables

Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Key Facts, 2017 2

Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 7

Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Shanghai Fosun Pharmaceutical (Group) Co Ltd, Deals By Market, 2012 to YTD 2018 9

Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

Paragon Genomics Raises USD8 Million in Series A Financing 13

Spirometrix Raises USD17.4 Million in Series C Financing 14

Check-Cap Raises Funds through Venture Financing 15

Saladax Biomedical Raises US Million In Series D Venture Financing 16

Butterfly Network Raises USD250 Million in Series D Financing 18

Healthy Harmony and Shanghai Fosun Pharma Acquire Chindex International in Going Private Transaction for USD461 Million 19

PBM Capital Acquires Breas Medical From GE Healthcare 21

KKR Receives Government Approval To Acquire 35% Stake In Gland Pharma For USD200 Million 22

Shanghai Fosun Pharma Plans to Form Joint Venture with Fosun International 23

Intuitive Surgical to Form Joint Venture with Shanghai Fosun Pharma 24

Astute Medical Enters into Distribution Agreement with Fosun Long March 25

CareFusion Enters into Distribution Agreement with Breas Medical for Vivo Line of Ventilators 26

Miacom Diagnostics Enters into Co-Marketing Agreement with Fosun Diagnostics 27

Shanghai Fosun Pharma Raises USD331 Million in Private Placement of Shares 28

Gland Pharma May Raise USD500 Million in IPO 30

Shanghai Fosun Pharma to Raise USD298.3 Million in Private Placement of Shares 31

Chindex to Raise USD38.2 Million in Private Placement of Shares 33

Shanghai Fosun Pharma Raises USD190.7 Million in Public Offering of 5.1% Bonds Due 2023 34

Shanghai Fosun Pharma to Raise USD791 Million in Public Offering of Bonds 35

Shanghai Fosun Pharma Plans to Raise up to USD1 Billion in Private Placement of Bonds 36

Shanghai Fosun Pharma Raises USD65.3 Million in First Tranche of Private Placement of 3.95% Notes Due 2018 37

Shanghai Fosun Pharma to Acquire 65% Stake in SinoMedCare Biotech for USD40 Million 38

Fosun Pharma Acquires 80% stake in Breas Medical 39

Breas Medical Acquires B&D Electromedical 40

Shanghai Fosun Pharma Acquires 37% Stake in miacom diagnostics 41

Shanghai Fosun to Acquire 35% Stake in Sinopharm Holding Medical Investment Management from Sinopharm Group for up to USD32.4 Million 42

Fosun Pharma And Pramerica-Fosun China Opportunity Fund Complete Acquisition Of 95.6% Stake In Alma Lasers For US0 Million 43

Shanghai Fosun Pharma Acquires 17.65% Stake In SD Biosensor, In Vitro Diagnostics Company 45

Shanghai Fosun Pharmaceutical (Group) Co Ltd, Key Competitors 46

Shanghai Fosun Pharmaceutical (Group) Co Ltd, Key Employees 47

Shanghai Fosun Pharmaceutical (Group) Co Ltd, Subsidiaries 49

List Of Figures, Charts and Diagrams
in Shanghai Fosun Pharmaceutical (Group) Co Ltd (600196) - Medical Equipment - Deals and Alliances Profile [Report Updated: 23-10-2018]

List of Figures

Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 7

Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

Additional Details

Publisher

Global Data

Publisher Information

Reference

226033 | GDME138889D

Number of Pages

68

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196) - Financial and Strategic SWOT Analysis Review
SummaryShanghai Fosun Pharmaceutical (Group) Co., Ltd. (Fosun Pharma) is a biopharmaceutical and hea...
09 Jan 2016 by Global Data USD $300 More Info
Shanghai Jiao Da Onlly Co., Ltd. (600530) - Financial and Strategic SWOT Analysis Review
SummaryShanghai Jiao Da Onlly Co., Ltd. (SJDO) is a pharmaceutical company that develops, produces a...
09 Jan 2016 by Global Data USD $300 More Info
Shanghai Shenqi Pharmaceutical Investment Management Co.,Ltd. (600613) - Financial and Strategic SWOT Analysis Review
SummaryShanghai Shenqi Pharmaceutical Investment Management Co.,Ltd. (Shanghai Shenqi), formerly kno...
09 Jan 2016 by Global Data USD $300 More Info
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196) - Financial and Strategic SWOT Analysis Review
SummaryShanghai Fosun Pharmaceutical (Group) Co., Ltd. (Fosun Pharma) is a biopharmaceutical and hea...
08 Nov 2015 by Global Data USD $300 More Info
Shanghai Jiao Da Onlly Co., Ltd. (600530) - Financial and Strategic SWOT Analysis Review
SummaryShanghai Jiao Da Onlly Co., Ltd. (SJDO) is a pharmaceutical company that develops, produces a...
08 Nov 2015 by Global Data USD $300 More Info
Shanghai Shenqi Pharmaceutical Investment Management Co.,Ltd. (600613) - Financial and Strategic SWOT Analysis Review
SummaryShanghai Shenqi Pharmaceutical Investment Management Co.,Ltd. (Shanghai Shenqi), formerly kno...
08 Nov 2015 by Global Data USD $300 More Info
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. (1349) - Financial and Strategic SWOT Analysis Review
SummaryShanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. (FDZJ), a subsidiary of Shanghai Pharm...
08 Nov 2015 by Global Data USD $300 More Info
Shanghai Furen Industrial (Group) Co., Ltd. (600781) - Financial and Strategic SWOT Analysis Review
SummaryShanghai Furen Industrial (Group) Co., Ltd. (Shanghai Furen) is a pharmaceutical company. The...
08 Nov 2015 by Global Data USD $300 More Info
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196) - Medical Equipment - Deals and Alliances Profile
SummaryShanghai Fosun Pharmaceutical (Group) Co., Ltd. (Fosun Pharma) is a biopharmaceutical and hea...
23 Oct 2015 by Global Data USD $250 More Info
Shanghai MicroPort Medical (Group) Co., Ltd. - Medical Equipment - Deals and Alliances Profile
SummaryShanghai MicroPort Medical (Group) Co., Ltd. (MicroPort), formerly MicroPort Medical (Shangha...
23 Oct 2015 by Global Data USD $250 More Info

This report is published by Global Data

Download Free Report Summary PDF

Shanghai Fosun Pharmaceutical (Group) Co Ltd (600196) - Medical Equipment - Deals and Alliances Profile [Report Updated: 23-10-2018] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...

  • Allied Market Research
  • CBR Pharma
  • Current Partnering
  • Firstword
  • Global Data
  • Global Markets Direct
  • ICD Research
  • Infinti Research Technavio
  • Marketline
  • Markets and Markets
  • Micro Markets Monitor
  • MP Advisors
  • Venture Planning Group
  • GMR Data